The Business Research Company’s Cardiovascular Devices Global Market Report 2021: COVID-19 Impact And Recovery To 2030
LONDON, GREATER LONDON, UK, October 13, 2021 /EINPresswire.com/ — According to the new market research report ‘Cardiovascular Devices Cardiovascular Devices Global Market Report 2021: COVID-19 Impact And Recovery’ published by The Business Research Company, the cardiovascular devices market is expected to grow from $46.93 billion in 2020 to $51.9 billion in 2021 at a compound annual growth rate (CAGR) of 10.6%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cardiovascular devices market is expected to reach $66.15 billion in 2025 at a CAGR of 6%.
Request For A Sample For The Global Cardiovascular Devices Market Report:
The cardiovascular devices market consists of sales of cardiovascular devices and related services by entities (organizations, sole traders and partnerships) that produce cardiovascular devices used in diagnosing and treating cardiovascular diseases.
Trends In The Global Cardiovascular Devices Market
Leadless pacemakers are being used for certain medical conditions such as slow heart rate (bradycardia), as they provide a less-invasive alternative to conventional pacemakers. A leadless pacemaker is a self-contained device which is inserted in the right ventricle of the heart without incisional access, leads, or a surgical pocket. Furthermore, the medical procedure for leadless pacemaker can be performed in under 30 minutes, with few postprocedural restrictions. These devices are gaining popularity as they eliminate complications related to lead placement which include cardiac perforation, pneumothorax and lead dislodgement. Major companies manufacturing leadless pacemakers are Medtronic and Abbott.
Global Cardiovascular Devices Market Segments:
The global cardiovascular devices market is further segmented:
By Type: Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment
By End User: Hospitals And Clinics, Diagnostic Laboratories, Others
By Type of Expenditure: Public, Private
By Product: Instruments/Equipment, Disposables
By Geography: The global cardiovascular devices market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American cardiovascular devices market accounts for the largest share in the global cardiovascular devices market.
Read More On The Report For The Global Cardiovascular Devices Market At:
Cardiovascular Devices Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides cardiovascular devices global market overviews, analyzes and forecasts market size and growth for the global cardiovascular devices market, cardiovascular devices global market share, cardiovascular devices global market players, cardiovascular devices global market segments and geographies, cardiovascular devices global market’s leading competitors’ revenues, profiles and market shares. The cardiovascular devices global market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Cardiovascular Devices Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Cardiovascular Devices Market Organizations Covered: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc, Edwards Lifesciences.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Here is a list of reports from The Business Research Company similar to the Cardiovascular Devices Global Market Report 2021:
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2021 – By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), By End User (Hospitals, Ambulatory Surgical Centers, Physicians Clinics), By Application (Bradycardia, Tachycardia, Heart Failure), By Pacemakers (Implantable Pacemakers, External Pacemakers), By Defibrillators (Implantable Cardioverter Defibrillators, External Defibrillator), By Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillators (CRT-D), CRT-Pacemakers (CRT-P)), COVID-19 Impact And Recovery
Interventional Cardiology Devices And Equipment Global Market Report 2021 – By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices), By Application (Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers), COVID-19 Impact And Recovery
Cardiovascular Surgery Devices And Equipment Global Market Report 2021 – By Product Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), By End User (Home And Ambulatory Care, Hospitals, Diagnostic Laboratories, Research Laboratories), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications), COVID-19 Impact And Recovery
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293